Skip to content

13F-HR filed by Amalgamated Financial Corp.

Amalgamated Financial Corp. filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 3,002 holding rows worth $12,592,024,000.

Accession
0001823608-22-000095
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 3,002 entries on the cover page, a total value of $12,592,024,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $12,592,024,000 with VALUE read as thousands by filing date, 13F file number 028-22502. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PREVAIL THERAPEUTICS INC CVR741CVR013COM2,131$0thousands by filing dateValue filed as zero, left out of ratios.
DOVA PHARMACEUTICALS CVR259CVR017COM1,568$0thousands by filing dateValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001823608-22-000095this filing2022-05-16acceptance time not in the bulk data set